battle of glp-1 delivery technologies Battle of GLP-1 delivery technologies

No matter how hard you try, they keep coming back

MONDAY, Nov

Semaglutide injection timing can affect appetite control and side effects

Anita Petruzzelli offers GLP-1 Weight Loss Injections to patients in the New Haven, Hartford, and Waterbury areas.

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

GLP-1 receptor agonists and hormonal birth control can be used together safely in most cases, though gastrointestinal effects may reduce oral contraceptive absorption in rare instances